의료기술 인사이트

The European laparoscopic device market will witness minor expansion through 2022 owing to ongoing procedure growth (especially for bariatric surgeries in France), rising demand for increasingly…

The US market for gynecological devices declined in 2013 due mainly to decreased sales of PFR, vaginal sling, and GEA devices; however, the market will rebound and growth will gradually…

The market for orthopedic devices in Japan has exhibited steady procedural growth but will continue to be limited throughout the forecast period by biennial reimbursement cuts and a stringent…

The Chinese market for CRM devices will experience robust growth through 2022, driven primarily by rising use of this technology to treat arrhythmia and heart failure. This Medtech 360 Report…

Although hearing impairment remains a severely underaddressed condition in the US, the hearing aid device market will only experience moderate growth because of the lack of reimbursement available…

Despite the maturity of several product segments, changes in CMS reimbursement guidelines supporting a shift toward pay-for-performance and penalties for hospital readmissions will result in…

The market for trauma devices and reconstructive joint implants in the Asia Pacific markets will exhibit double-digit growth for many years and will continue to be driven by significant procedural…

The US neurostimulation device market is dynamic and will expand rapidly through 2022. This market will be characterized by new indication and novel device approvals. This Medtech 360 Report…

The US pain management device report will show strong market growth, driven by expanding demographics and an heightening focus on overall pain management; however, reimbursement cuts and pricing…

The global therapeutic BTX market will be grow robustly through 2022, with significant procedure and unit sales growth being driven by newly approved indications, the need for repeat BTX …

The market for trauma devices and reconstructive joint implants in the Asia Pacific markets will exhibit steady double-digit growth for many years and will continue to be driven by significant…

The US market for nonbreast aesthetic implants will exhibit modest declines through 2022 as patient demand for less invasive treatment options increases. This Medtech 360 Report provides…